Pre-clinical studies on pharmacokinetics and pharmacodynamics of col-3, a matrix metalloproteinase inhibitor: Single agent and in combination with doxorubicin

Pre-clinical studies on pharmacokinetics and pharmacodynamics of col-3, a matrix metalloproteinase inhibitor: Single agent and in combination with doxorubicin

Ph.D

Saved in:

書目詳細資料
主要作者:	LI JING
其他作者:	PHARMACY
格式:	Theses and Dissertations
語言:	English
出版:	2019
主題:	COL-3; matrix metalloproteinase inhibitor; doxorubicin; pharmacokinetics; pharmacodynamics; drug interaction
在線閱讀:	https://scholarbank.nus.edu.sg/handle/10635/161046
標簽:	添加標簽沒有標簽, 成為第一個標記此記錄!

相似書籍

Alteration of the pharmacokinetics of COL-3, a matrix metalloproteinase inhibitor, due to acute gastrointestinal toxicity of doxorubicin
由: Li, J., et al.
出版: (2014)

Reversed-phase liquid chromatography method to determine COL-3, a matrix metalloproteinase inhibitor, in biological samples
由: Li, J., et al.
出版: (2014)

PHARMACODYNAMICS, PHARMACOKINETICS AND PHARMACOGENETICS OF DOXORUBICIN IN SINGAPOREAN BREAST CANCER PATIENTS
由: FAN LU
出版: (2011)

Evidence for dissolution rate-limited absorption of COL-3, a matrix metalloproteinase inhibitor, leading to the irregular absorption profile in rats after oral administration
由: Li, J., et al.
出版: (2014)

Investigating the influence of Age on Pharmacokinetic and Pharmacodynamic characteristics of Gold standard Alzheimer's Disease drugs in the lister - Hooded Rat.
由: GOH WENHUI, CATHERINE
出版: (2010)

Optimizing dihydroartemisinin-piperaquine dose regimens in a paediatric population: a pharmacokinetic-pharmacodynamic approach using monte-carlo simulations
由: Palang Chotsiri, et al.
出版: (2015)

Phase I and pharmacodynamic study of an orally administered novel inhibitor of histone deacetylases, SB939, in patients with refractory solid malignancies
由: Yong, W.P., et al.
出版: (2014)

Pharmacokinetic and pharmacodynamic studies of mycophenolic acid in renal transplant recipients
由: NWAY NWAY AYE
出版: (2010)

Population Pharmacokinetics/Pharmacodynamics and Clinical Outcomes of Carbapenems in Critically Ill Patients
由: Apinya Boonpeng
出版: (2022)

Effect of ubidecarenone on warfarin anticoagulation and pharmacokinetics of warfarin enantiomers in rats
由: Zhou, S., et al.
出版: (2014)

Effect of omeprazole on the anticoagulant activity and the pharmacokinetics of warfarin enantiomers in rats
由: Zhou, Q., et al.
出版: (2014)

Effect of rutin on warfarin anticoagulation and pharmacokinetics of warfarin enantiomers in rats
由: Chan, E., et al.
出版: (2014)

Pharmacokinetics of intravenously administered stealth liposomal doxorubicin modulated with verapamil in rats
由: Wang, J.-C., et al.
出版: (2011)

The role of matrix metalloproteinases (MMP) and their inhibitor in influenza A virus-induced host lung injury
由: NG HUEY HIAN
出版: (2011)

Pharmacokinetics-Pharmacodynamics Driven Approach for Lead Optimization in Anti-Mycobacterial and Anti-Malarial Drug Discovery
由: SURESH BANGALORE LAKSHMINARAYANA
出版: (2015)

Pharmacokinetics and pharmacodynamics of intravenous artesunate during severe malaria treatment in Ugandan adults.
由: Byakika-Kibwika, Pauline, et al.
出版: (2014)

Pharmacokinetic and pharmacodynamic mechanisms for reduced toxicity of CPT-11 by thalidomide and St John's wort
由: YANG XIAOXIA
出版: (2010)

Statistical learning approach for predicting specific pharmacodynamic, pharmacokinetic, or toxicological properties of pharmaceutical agents
由: Li, H., et al.
出版: (2014)

FORMULATION DEVELOPMENT AND BRAIN DELIVERY OF ANTIOXIDANT AND ANTI-INFLAMMATORY DRUGS AS POTENTIAL TREATMENT OF ALZHEIMER'S DISEASE: PHARMACOKINETICS, PHARMACODYNAMICS, AND METABOLOMICS
由: ZHANG LI
出版: (2021)

Effect of 5-fluorouracil on the anticoagulant activity and the pharmacokinetics of warfarin enantiomers in rats
由: Zhou, Q., et al.
出版: (2014)

Significant intestinal excretion, one source of variability in pharmacokinetics of COL-3, a chemically modified tetracycline
由: Li, J., et al.
出版: (2014)

Body fat composition impacts the hematologic toxicities and pharmacokinetics of doxorubicin in Asian breast cancer patients
由: Wong, A.L., et al.
出版: (2014)

PHARMACOKINETIC AND PHARMACODYNAMIC STUDIES OF THE NOVEL ANTICOAGULANT PEPTIDE VARIEGIN IN RATS AND PIGS
由: NORRAPAT SHIH
出版: (2016)

Predicting Asian glycemic responses in food using a physiologically-based pharmacokinetic-pharmacodynamic model
由: Koh, Hor Cheng
出版: (2025)

Prediction of compounds with specific pharmacodynamic, pharmacokinetic or toxicological property by statistical learning methods
由: Yap, C.W., et al.
出版: (2014)

In vivo and in vitro study on potential combination therapy of COL-3 and tamoxifen in breast cancer: a pilot study
由: ZHENG LIN
出版: (2010)

On-line chromatographic screening of matrix metalloproteinase inhibitors using immobilized MMP-9 enzyme reactor
由: Ma, X., et al.
出版: (2014)

Integrin à2?1 expression regulates matrix metalloproteinase-1-dependent bronchial epithelial repair in pulmonary tuberculosis
由: Brilha S., et al.
出版: (2019)

Accuracy of repeated blood sampling in rats: A new technique applied in pharmacokinetic/pharmacodynamic studies of the interaction between warfarin and co-enzyme Q10
由: Zhou, Q., et al.
出版: (2014)

Broccoli and watercress suppress matrix metalloproteinase-9 activity and invasiveness of human MDA-MB-231 breast cancer cells
由: Rose, P., et al.
出版: (2011)

HARNESSING MOLECULAR MECHANISMS OF DRUG RESISTANCE TO REVERT RESISTANCE TO TOP2 INHIBITORS (DOXORUBICIN)
由: CORONEL CARRION LUIS EDUARDO
出版: (2017)

Proton pump inhibitors: Do differences in pharmacokinetics translate into differences in clinical outcomes?
由: Fock, K.M., et al.
出版: (2016)

Expression of matrix metalloproteinases (MMP-2 and MMP-7) mRNAs in human gastric cancer
由: Huang, Y., et al.
出版: (2011)

Regression methods for developing QSAR and QSPR models to predict compounds of specific pharmacodynamic, pharmacokinetic and toxicological properties
由: Yap, C.W., et al.
出版: (2014)

Regression methods for developing QSAR and QSPR models to predict compounds of specific pharmacodynamic, pharmacokinetic and toxicological properties
由: Yap, C.W., et al.
出版: (2014)

EXPLORING THE ROLE OF PHARMACOKINETIC ALTERATIONS IN TYROSINE KINASE INHIBITORS (TKIS)-ASSOCIATED TOXICITIES
由: TEO YI LING
出版: (2015)

Fluvastatin: Efficacy and safety in reducing cardiac events
由: Chan, M.Y., et al.
出版: (2016)

Clinical experience with high-dose polymyxin b against carbapenem-resistant gram-negative bacterial infections—a cohort study
由: Cai, Y., et al.
出版: (2021)

Resveratrol for cancer therapy: Challenges and future perspectives
由: Ren, Boxu, et al.
出版: (2022)

Pharmacokinetics of prenylflavonoids and correlations with the dynamics of estrogen action in sera following ingestion of a standardized Epimedium extract
由: Wong, S.P., et al.
出版: (2011)